Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/31227
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gürcan, Şaban | - |
dc.contributor.author | Konuk, Emel | - |
dc.contributor.author | Kılıç, Haluk | - |
dc.contributor.author | Otkun, Metin | - |
dc.date.accessioned | 2023-02-28T05:35:20Z | - |
dc.date.available | 2023-02-28T05:35:20Z | - |
dc.date.issued | 2007-04-26 | - |
dc.identifier.citation | Gürcan, Ş. vd. (2007). "Sporotrichosis, a disease rarely reported from Turkey, and an overview of Turkish literature". Mycoses, 50(5), 426-429. | en_US |
dc.identifier.issn | 0933-7407 | - |
dc.identifier.uri | https://doi.org/10.1111/j.1439-0507.2007.01392.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1439-0507.2007.01392.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/31227 | - |
dc.description.abstract | Sporothrix schenckii causes clinical cutaneous forms consisting of lymphangitic, localised, disseminated or extracutaneous forms of sporotrichosis. Cutaneous form caused by the agent entering the body through the skin after trauma is the most frequently seen sporotrichosis form and it progresses in the form of either nodular lymphangitic lesions or localised (fix) lesions (da Rosa AC et al., J Am Acad Dermatol 2005; 52: 451–9; Schamroth JM, Grieve TP, Kellen P. Int J Dermatol 1988; 27: 28–30). Causative agent entering the body through skin causes erythematous, ulcerative or verrucous nodules and lesions generally progress to nodular lymphangitic cutaneous sporotrichosis (Kwon-Chung KJ, Bennett JE. Medical Mycology, Lea & Febiger, Philadelphia–London, 1992: 707–29). Lymphangitic sporotrichosis (nodular lymphangitic cutaneous sporotrichosis) accounts for 70–80% of the total number of the cases (Vismer HF, Hull PR. Mycopathologia 1997; 137: 137–43). The case presented in this paper is that of patient with a sporotrichosis in nodular lymphangitic cutaneous form which developed after the prick of a thorn in hand. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Dermatology | en_US |
dc.subject | Mycology | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antifungal agents | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Naphthalenes | en_US |
dc.subject.mesh | Potassium iodide | en_US |
dc.subject.mesh | Rare diseases | en_US |
dc.subject.mesh | Sporothrix | en_US |
dc.subject.mesh | Sporotrichosis | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.mesh | Turkey | en_US |
dc.title | Sporotrichosis, a disease rarely reported from Turkey, and an overview of Turkish literature | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000249207800106 | tr_TR |
dc.identifier.scopus | 2-s2.0-34547904633 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-4803-8206 | tr_TR |
dc.identifier.startpage | 426 | tr_TR |
dc.identifier.endpage | 429 | tr_TR |
dc.identifier.volume | 50 | tr_TR |
dc.identifier.issue | 5 | tr_TR |
dc.relation.journal | Mycoses | en_US |
dc.contributor.buuauthor | Ener, Beyza | - |
dc.contributor.researcherid | AAG-8523-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 17714365 | tr_TR |
dc.subject.wos | Dermatology | en_US |
dc.subject.wos | Mycology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 15053025300 | tr_TR |
dc.subject.scopus | Antifungal Agents; Exoantigens; Itraconazole | en_US |
dc.subject.emtree | Amoxicillin plus clavulanic acid | en_US |
dc.subject.emtree | Amphotericin b | en_US |
dc.subject.emtree | Antiinfective agent | en_US |
dc.subject.emtree | Batticon | en_US |
dc.subject.emtree | Cefuroxime axetil | en_US |
dc.subject.emtree | Chloramphenicol | en_US |
dc.subject.emtree | Ciprofloxacin | en_US |
dc.subject.emtree | Fluconazole | en_US |
dc.subject.emtree | Fusidic acid | en_US |
dc.subject.emtree | Itraconazole | en_US |
dc.subject.emtree | Ketoconazole | en_US |
dc.subject.emtree | Ornidazole | en_US |
dc.subject.emtree | Potassium iodide | en_US |
dc.subject.emtree | Procaine penicillin | en_US |
dc.subject.emtree | Thiocillin | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Voriconazole | en_US |
dc.subject.emtree | Add on therapy | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Conidium | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Erythema | en_US |
dc.subject.emtree | Erythrocyte sedimentation rate | en_US |
dc.subject.emtree | Fungal colonization | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Microscopy | en_US |
dc.subject.emtree | Minimum inhibitory concentration | en_US |
dc.subject.emtree | Physical examination | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Pus | en_US |
dc.subject.emtree | Skin nodule | en_US |
dc.subject.emtree | Skin ulcer | en_US |
dc.subject.emtree | Sporothrix schenckii | en_US |
dc.subject.emtree | Sporotrichosis | en_US |
dc.subject.emtree | Treatment duration | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.